Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC-Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?
1 Tissue Pathology and Diagnostic Oncology, NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; School of Medicine, Western Sydney University, Sydney, Australia. Electronic address: Wendy.Cooper@health.nsw.gov.au.
2 Institute for Advanced Biosciences, University Grenoble Alpes, Grenoble, France; Department of Biopathology, Centre Leon Berard Unicancer and Pathology Research Platform, Cancer Research Center of Lyon (CRCL), Lyon, France.
3 Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.